# Aerosolized Surfactant in Neonatal RDS

> **NCT02294630** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sood, Beena G., MD, MS** · enrollment: 159 (actual)

## Conditions studied

- Respiratory Distress Syndrome, Newborn

## Interventions

- **DRUG:** Surfactant

## Key facts

- **NCT ID:** NCT02294630
- **Lead sponsor:** Sood, Beena G., MD, MS
- **Sponsor class:** INDIV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2019-07
- **Final completion:** 2020-07
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02294630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02294630, "Aerosolized Surfactant in Neonatal RDS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02294630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*